GlaxoSmithKline Director of Business Development Salaries in Newark, NJ
The average GlaxoSmithKline Director of Business Development in Newark, NJ earns an estimated $184,976 annually, which includes an estimated base salary of $144,351 with a $40,625 bonus. GlaxoSmithKline's Director of Business Development compensation is $18,710 more than the US average for a Director of Business Development. Director of Business Development salaries at GlaxoSmithKline in Newark, NJ can range from $120,000 - $270,000.
In Newark, NJ, The Business Development Department at GlaxoSmithKline earns $3,337 more on average than the HR Department.
Last updated 2 years ago.
- $144,351
- avg. base
- $40,625
- avg. bonus
Director of Business Development Salaries at GlaxoSmithKline
In Newark, NJ, Directors of Business Development earn $28,440 more than Business Development Managers, and $366 less than Directors of Business Development.
Compensation at GlaxoSmithKline by Department
In Newark, NJ, The Business Development Department averages $3,337 more than the HR Department, and $3,636 less than the Marketing Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to GlaxoSmithKline reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to GlaxoSmithKline reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at GlaxoSmithKline Rate Their Compensation
The majority of Directors of Business Development at GlaxoSmithKline believe they're compensated fairly. 100% of Directors of Business Development at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline
